National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 10) (No. PB 71 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L01813

 
PB 71 of 2013
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 10)
 
National Health Act 1953
___________________________________________________________________________
 
I, Steve Dunlop, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated   16    October 2013
 
 
 
 
 
 
 
 
 
 
 
 
STEVE DUNLOP
Acting Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health
 
___________________________________________________________________
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.10).
 
(2)                This Instrument may also be cited as PB 71 of 2013.
 
2             Commencement
                This Instrument commences on 1 November 2013.
3              Amendments to PB 79 of 2011
                      Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).
 
 
Schedule 1                   Amendments
 
[1]    Schedule 1 Part 1, under the entry for the listed drug Docetaxel, in the form ‘Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent’ with manner of administration ‘Injection’
omit:
Taxotere
SW
MP
C3888 C3892 C3916
C3956
C4078
C4140
C4160
C4239
D
 
Read Entire Law on www.comlaw.gov.au